Lisinopril formulations
US11771733B2 · kind B2 · utility
2Cited by
32References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 21, 2021 |
| Grant date | Oct 3, 2023 |
| Priority date | — |
| Expiry date | Oct 21, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.